Polymorphisms rs2745557 in PTGS2 and rs2075797 in PTGER2 are associated with the risk of chronic obstructive pulmonary disease development in a Tunisian cohort.


Journal

Prostaglandins, leukotrienes, and essential fatty acids
ISSN: 1532-2823
Titre abrégé: Prostaglandins Leukot Essent Fatty Acids
Pays: Scotland
ID NLM: 8802730

Informations de publication

Date de publication:
03 2021
Historique:
received: 01 10 2020
revised: 25 01 2021
accepted: 27 01 2021
pubmed: 6 2 2021
medline: 21 12 2021
entrez: 5 2 2021
Statut: ppublish

Résumé

We hypothesized that polymorphisms of genes involved in the prostaglandin pathway could be associated with COPD. In this study we explored the involvement of genetic polymorphisms in PTGS2, PTGER2 and PTGER4 genes in the development and severity of COPD and their effects on plasma concentrations of inflammatory/oxidative stress markers. We identified genotypes of PTGS2, PTGER2 and PTGER4 SNPs in a Tunisian cohort including COPD patients (n = 138) and control subjects (n = 216) using PCR-RFLP and PCR TaqMan. Pulmonary function (FEV1 and FVC) were assessed by plethsmography. PGE

Identifiants

pubmed: 33545665
pii: S0952-3278(21)00015-6
doi: 10.1016/j.plefa.2021.102252
pii:
doi:

Substances chimiques

Cytokines 0
PTGER2 protein, human 0
PTGER4 protein, human 0
Receptors, Prostaglandin E, EP2 Subtype 0
Receptors, Prostaglandin E, EP4 Subtype 0
Cyclooxygenase 2 EC 1.14.99.1
PTGS2 protein, human EC 1.14.99.1
Dinoprostone K7Q1JQR04M
Prostaglandin D2 RXY07S6CZ2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102252

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Auteurs

Salma Mani (S)

Sorbonne Paris nord University, 93430 Villetaneuse, France; INSERM, UMRS1148, CHU X.Bichat, Paris, France; Institut supérieur de biotechnologies de Monastir, University of Monastir, Tunisia; UR12ES06, Physiologie de l'exercice et physiopathologie: de l'intégré au moléculaire, Faculté de médecine de Sousse, University of Sousse, Tunisia. Electronic address: salma.mani@inserm.fr.

Xavier Norel (X)

Sorbonne Paris nord University, 93430 Villetaneuse, France; INSERM, UMRS1148, CHU X.Bichat, Paris, France.

Mathilde Varret (M)

INSERM, UMRS1148, CHU X.Bichat, Paris, France; Université de Paris, France.

Sarra Bchir (S)

Institut supérieur de biotechnologies de Monastir, University of Monastir, Tunisia; UR12ES06, Physiologie de l'exercice et physiopathologie: de l'intégré au moléculaire, Faculté de médecine de Sousse, University of Sousse, Tunisia.

Amel Ben Anes (A)

UR12ES06, Physiologie de l'exercice et physiopathologie: de l'intégré au moléculaire, Faculté de médecine de Sousse, University of Sousse, Tunisia.

Abdelahamid Garrouch (A)

Service de pneumo-allergologie, CHU Farhat Hached, Sousse, Tunisia.

Zouhair Tabka (Z)

UR12ES06, Physiologie de l'exercice et physiopathologie: de l'intégré au moléculaire, Faculté de médecine de Sousse, University of Sousse, Tunisia.

Dan Longrois (D)

Sorbonne Paris nord University, 93430 Villetaneuse, France; INSERM, UMRS1148, CHU X.Bichat, Paris, France; Université de Paris, Assistance Publique-Hôpitaux de Paris,Hôpital Bichat-Claude Bernard, DMU PARABOL, Paris, France.

Karim Chahed (K)

UR12ES06, Physiologie de l'exercice et physiopathologie: de l'intégré au moléculaire, Faculté de médecine de Sousse, University of Sousse, Tunisia; Faculté des sciences de Sfax, University of Sfax, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH